On Invalid Date, Immatics Nv (NASDAQ: IMTX) reported Q4 2023 earnings per share (EPS) of -$0.33, up 35.92% year over year. Total Immatics Nv earnings for the quarter were -$29.05 million. In the same quarter last year, Immatics Nv's earnings per share (EPS) was -$0.25.
As of Q2 2024, Immatics Nv's earnings has grown year over year. Immatics Nv's earnings in the past year totalled -$105.43 million.
What is IMTX's earnings date?
Immatics Nv's earnings date is Invalid Date. Add IMTX to your watchlist to be reminded of IMTX's next earnings announcement.
What was IMTX's revenue last quarter?
On Invalid Date, Immatics Nv (NASDAQ: IMTX) reported Q4 2023 revenue of $17.69 million up 55.83% year over year. In the same quarter last year, Immatics Nv's revenue was $40.05 million.
What was IMTX's revenue growth in the past year?
As of Q2 2024, Immatics Nv's revenue has grown -67.37% year over year. This is 221.22 percentage points lower than the US Biotechnology industry revenue growth rate of 153.85%. Immatics Nv's revenue in the past year totalled $58.69 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.